Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Insys Therapeutics Inc.

www.insysrx.com

Latest From Insys Therapeutics Inc.

Teva Seeks Global Resolution Of Opioid Litigation

Teva and three distributors settle with two plaintiffs; PBMs are defendants in next case as Teva also reaches an agreement in principal with four attorneys general for global settlement framework.

Legal Issues Strategy

Teva Seeks Global Resolution Of Opioid Litigation As Bellwether Trial Is Halted

Teva and three distributors settle with two plaintiffs; PBMs are defendants in next case as Teva also reaches an agreement in principal with four attorneys general for global settlement framework. 

Legal Issues Advertising, Marketing & Sales

J&J Settlement Leaves Teva As Sole Opioid Maker In Bellwether Trial

Four distributors and Walgreens also remain defendants; court to consider Teva's motion to dismiss if the trial results in a judgement against its subsidiaries. Seven-week trial could include 215 witnesses and 21,000 exhibits.

Legal Issues Advertising, Marketing & Sales

Purdue's Opioid Rescue Drug Development To Continue Under A New Company

Purdue proposes continuing the development of nalmefene hydrochloride and other products under a new company that would provide the products at no or low cost.

Companies Research & Development
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Cancer
  • Gastrointestinal
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Insys Therapeutics Inc.
  • Senior Management
  • Andrew G Long, CEO
    Andrece G Housley, CFO
    Steve Sherman, SVP, Reg. Affairs
    Venkat R Goskonda, PhD, SVP, R&D
    Vikram Malhotra, VP, Corp. Dev.
    Venkat Goskonda, PhD, CSO
  • Contact Info
  • Insys Therapeutics Inc.
    Phone: (602) 910-2617
    1333 S Spectrum Blvd.
    #100
    Chandler, AZ 85286
    USA
UsernamePublicRestriction

Register